Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LeMaitre acquires endograft maker

This article was originally published in The Gray Sheet

Executive Summary

EndoMed will maintain its Phoenix manufacturing facilities for the time being, but will relocate corporate business to LeMaitre Vascular's Burlington, Mass. headquarters. The privately held vascular company completed the EndoMed purchase for an undisclosed price Feb. 2. EndoMed is in Phase I clinical trials to gain premarket approval for its Endofit endovascular stent graft, CE-marked in Europe. Last April, LeMaitre began a trial to support U.S. approval of its Expedial vascular access graft, acquired a year earlier from Credent Vascular Technologies. The randomized study - initially aiming to enroll 172 patients - has progressed more slowly than expected, LeMaitre says...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts